Delivery Order SPE2DB22D9239-SPE2DB24FDE60
- Not listed
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency to provide Cerdelga 84 mg capsules. The $30,046.61 order is for 14 capsules with a completion date of January 10, 2024. No set-aside designation was used for this award issued by the Defense Logistics Agency out of Park Ridge, Illinois. DMS Pharmaceutical Group holds this pharmaceutical prime vendor contract with the Defense Logistics...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency to provide Cerdelga 84 mg capsules. The $30,046.61 order calls for 14 units of the medication to be delivered to a facility in Park Ridge, Illinois by November 17, 2023. DMS Pharmaceutical Group holds this pharmaceutical prime vendor contract with the Defense Logistics Agency to directly supply prescription medications and services to support...
- The Defense Logistics Agency awarded a $30,105.64 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 14S of CERDELGA 84 MG CAPSULE under contract number 4562417305. The prime contractor DMS Pharmaceutical Group Inc. will deliver the pharmaceutical products to a location in Park Ridge, Illinois by October 19, 2023. The Defense Logistics Agency facilitates the delivery of medical supplies and pharmaceuticals to support the United States Department of Defense. This delivery...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a delivery order valued at $32,185.93 for Cerdelga 84 mg capsules (14-count packages). This firm fixed-price delivery order, issued on August 12, 2025, with an ultimate completion date of September 3, 2025, represents a specific product fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA. The company was...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $32,185.93 contract is for the delivery of CERDELGA 84 MG CAPSULE 14S, a pharmaceutical product. The order has an ultimate completion date of August 7, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $32,185.93, is for the delivery of Cerdelga 84 mg capsules. The contract has an ultimate completion date of July 10, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business (WOSB) organization. The $32,185.93 contract is for the delivery of CERDELGA 84 MG CAPSULE 14S, a pharmaceutical product. The contract has a completion date of February 16, 2024. DMS Pharmaceutical Group Inc. holds a broader indefinite delivery contract with the DLA, valued up to $4,999,999 through 2025, for the supply of a wide range...
- The Defense Logistics Agency, a component of the Department of Defense, awarded a firm fixed price delivery order valued at thirty thousand forty-six dollars and sixty-one cents ($30,046.61) to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. Under the contract, DMS Pharmaceutical Group will provide one hundred forty-four (144) capsules of Cerdelga, an orphan drug used to treat Gaucher disease, with performance taking place in Park Ridge through September 2029. No additional details were...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $32,185.93 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 84mg capsules of the pharmaceutical product CERDELGA. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $32,185.93, is for the delivery of CERDELGA 84 MG CAPSULE 14S, a pharmaceutical product, with a period of performance through April 30, 2025. The contract is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB24FDE60Delivery Order
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at thirty thousand forty-six dollars and sixty-one cents ($30,046.61) by the Defense Logistics Agency to provide fourteen hundred and fifty-six thousand two hundred ninety-eight (1,456,298) Cerdelga eighty-four (84) milligram capsules. The order is being issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical supplies with a potential value of up to five million dollars through December 2025. Performance is to be completed by December eighteenth, two thousand twenty-three. The products will be delivered to Defense Logistics Agency facilities in Park Ridge, Illinois to support military treatment operations. No set aside provision was applied to this order.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $30.0k | 11/27/23 |